Sorry, you need to enable JavaScript to visit this website.

LINCOCIN® (lincomycin HCl) Nonclinical Toxicology


In vivo experimental animal studies demonstrated the effectiveness of LINCOCIN preparations (lincomycin) in protecting animals infected with Streptococcus viridans,β-hemolytic Streptococcus, Staphylococcus aureus, Streptococcus pneumoniae and Leptospira pomona. It was ineffective in Klebsiella, Pasteurella, Pseudomonas, Salmonella and Shigella infections.

What's New

No Current Announcements.

Contact Pfizer Medical


Please enter your search term(s) for LINCOCIN®